Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human CCND3 Protein, N-His

Catalog #:   YHD88001 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P30281
Protein length: Met1-Leu292
Overview

Catalog No.

YHD88001

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Leu292

Predicted molecular weight

34.83 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P30281

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

CCND3, G1/S-specific cyclin-D3

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CCND3 protein
References

Olig1/2 Drive Astrocytic Glioblastoma Proliferation Through Transcriptional Co-Regulation of Various Cyclins., PMID:40428395

Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets., PMID:40299210

[Relapse-related candidate genes and their clinicopathological connections of diffuse large B cell lymphoma]., PMID:40159024

Small nucleolar RNAs promote the restoration of muscle differentiation defects in cells from myotonic dystrophy type 1., PMID:40156865

Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation., PMID:40059278

Establishment and characterization of a new mouse gastric carcinoma cell line, MCC., PMID:39800685

Downregulated CCND3 Is a Key Event Driving Lung Adenocarcinoma Metastasis during Acquired Cisplatin Resistance., PMID:39781469

Cyclin D1-negative mantle cell lymphoma., PMID:39571691

Cone-rod homeobox transcriptionally activates TCF7 to promote the proliferation of retinal pigment epithelial and retinoblastoma cells in vitro., PMID:39559312

Upregulated let-7 expression in the follicular fluid of patients with endometriomas leads to dysfunction of granulosa cells through targeting of IGF1R., PMID:39521729

ZNF652 exerts a tumor suppressor role in lung cancer by transcriptionally downregulating cyclin D3., PMID:39500884

Impaired cyclin D3 protein degradation contributes to trastuzumab resistance in HER2 positive breast cancer., PMID:39487929

Structural requirements for the specific binding of CRABP2 to cyclin D3., PMID:39419021

Hepatoid thymic carcinoma in a polycythemia vera patient treated with ropeginterferon Alfa-2b: Clinical, histopathological and molecular correlates., PMID:39405803

LncRNA Pvt1 aggravates cardiomyocyte apoptosis via the microRNA-216/Ccnd3 axis., PMID:39398060

Gaucher-like crystal-storing histiocytosis associated with kappa chain myeloma: A case report with next generation sequencing study., PMID:39357187

Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)., PMID:39298716

Testosterone-Induced H3K27 Deacetylation Participates in Granulosa Cell Proliferation Suppression and Pathogenesis of Polycystic Ovary Syndrome., PMID:39243944

Genomic analysis reveals molecular characterization of CD30+ and CD30- extranodal natural killer/T-cell lymphomas (ENKTLs)., PMID:39187207

PRAME promotes proliferation of multiple myeloma cells through CTMP/Akt/p21/CCND3 axis by ubiquitinating CTMP and p21., PMID:39071619

Post-GWAS Validation of Target Genes Associated with HbF and HbA2 Levels., PMID:39056767

Analysis of CCND3 mutations in diffuse large B-cell lymphoma., PMID:38886191

Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition., PMID:38853901

The application of proteomics and phosphoproteomics to reveal the molecular mechanism of salidroside in ameliorating myocardial hypoxia., PMID:38737233

A rare case of TFEB/6p21/VEGFA-amplified renal cell carcinoma diagnosed by whole-exome sequencing: clinicopathological and genetic feature report and literature review., PMID:38730456

Molecular Pathogenesis of Multiple Myeloma: Clinical Implications., PMID:38199896

A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse., PMID:38175437

The Cyclin D3 Protein Enforces Monogenic TCRβ Expression by Mediating TCRβ Protein-Signaled Feedback Inhibition of Vβ Recombination., PMID:38117277

First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results., PMID:38060199

The genetic landscape of histologically transformed marginal zone lymphomas., PMID:37941429

Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement., PMID:37882866

BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3., PMID:37594294

Circ_0001602 aggravates the progression of acute myeloid leukemia by regulating the miR-192-5p/ZBTB20 axis., PMID:37585722

IL-21 shapes germinal center polarization via light zone B cell selection and cyclin D3 upregulation., PMID:37466652

Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials., PMID:37424386

Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients., PMID:37418076

Incidental Detection of TFEB-Amplified Renal Cell Carcinoma by Colocated Gene Amplification of CCND3 (6p21): A Case Report and Review of the Literature., PMID:37394760

Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway., PMID:37263638

Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation., PMID:37055530

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma., PMID:37032379

High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases., PMID:36997031

Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma., PMID:36996377

Targeting diacylglycerol kinase α impairs lung tumorigenesis by inhibiting cyclin D3., PMID:36965165

Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells., PMID:36929658

Cyanidin-3-O-Glucoside Rescues Zearalenone-Induced Apoptosis via the ITGA7-PI3K-AKT Signaling Pathway in Porcine Ovarian Granulosa Cells., PMID:36901882

Whole-Blood Gene Expression Profiles Associated with Mortality in Community-Acquired Pneumonia., PMID:36830965

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome., PMID:36624313

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders., PMID:36620555

NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition., PMID:36573331

Losing CD45 and various B-cell markers in a case of MYC-driven pediatric high-grade B-cell lymphoma, not otherwise specified that transformed from Burkitt's lymphoma during rituximab-containing treatments: a case report., PMID:36383247

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CCND3 Protein, N-His [YHD88001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only